Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Role of Angiotensin-Converting Enzyme 2 in Covid-19 Induced Lung Injury Publisher Pubmed



Torabi S1 ; Bahreini F2, 3 ; Rezaei N3, 4, 5, 6
Authors

Source: Acta Biomedica Published:2020


Abstract

The novel coronavirus disease (COVID-19) has affected people around the world both physically and psychologically. As result, developing a coronavirus-specific vaccine and/or therapeutics is now a top priority for public health agencies. Since our findings of COVID-19 are relatively new, the current knowledge about the molecular mechanism involved in pathogenicity and virulence of the novel coronavirus is not advanced. Understanding angiotensin-converting enzyme 2 (ACE2), the receptor for the coronavirus, is significantly important. To better illustrate the role of ACE2 in the severity of COVID-19 and the impact of currently used drugs on this receptor, this paper briefly reviews newly published articles in this regard. (www.actabiomedica.it). © Mattioli 1885.
Other Related Docs
8. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
9. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
11. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
13. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
14. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
15. Crispr/Cas13: A Potential Therapeutic Option of Covid-19, Biomedicine and Pharmacotherapy (2020)